Ibuprofen does not raise PSA levels. If anything, the research leans in the opposite direction: anti-inflammatory drugs like ibuprofen may slightly lower PSA, though the effect appears small and studies disagree on whether it’s meaningful enough to matter clinically.
PSA (prostate-specific antigen) is a protein produced by prostate cells. Inflammation in the prostate can push PSA levels higher, so it’s reasonable to wonder whether an anti-inflammatory drug might pull them down. The answer is nuanced and depends on which type of anti-inflammatory you’re taking and how often.
What the Research Actually Shows
Studies on ibuprofen and similar non-aspirin NSAIDs have produced inconsistent results, but none suggest these drugs raise PSA. A study published in the Journal of Urology found that non-aspirin NSAIDs (a category that includes ibuprofen and naproxen) showed no statistically significant effect on PSA levels. Users and non-users had nearly identical readings (8.7 vs. 8.9 ng/ml), a difference so small it could easily be random noise.
A separate study of men at high risk for prostate cancer reached the same conclusion. After adjusting for age, race, BMI, and smoking history, chronic NSAID use had no significant association with PSA levels or with how fast PSA changed over time (a measurement called PSA velocity). The researchers specifically examined long-term, regular users and still found no meaningful effect.
Aspirin Is the Outlier, Not Ibuprofen
Where things get more interesting is with aspirin. Unlike ibuprofen, aspirin has shown a consistent ability to lower PSA in multiple studies. In one analysis, PSA levels were roughly 9% lower among aspirin users compared to non-users, even after controlling for prostate size. Another study found the gap was even larger: aspirin users who had never smoked had PSA values about 49% lower than non-users, while those who had ever smoked showed a 24% reduction.
Ibuprofen and other non-aspirin NSAIDs did not show this same pattern. When researchers isolated non-aspirin NSAID users, the percentage difference in PSA was only about 5% overall, and statistically insignificant. This suggests that whatever mechanism drives aspirin’s effect on PSA, ibuprofen doesn’t share it to the same degree. Aspirin works differently from ibuprofen at a cellular level: it irreversibly blocks the enzymes involved in inflammation, while ibuprofen’s block is temporary. That distinction likely matters here.
Could NSAIDs Mask a Problem?
The concern some men have is straightforward: if a pain reliever lowers PSA, could it hide an elevated reading that would otherwise flag prostate cancer? For ibuprofen specifically, this worry appears unfounded based on current evidence. The data consistently shows that non-aspirin NSAIDs don’t move PSA in a clinically meaningful way.
For aspirin, the question is more legitimate. A 30% or greater reduction in PSA could theoretically push a borderline result below the threshold that triggers further testing. The American Urological Association notes that medications can suppress PSA levels and recommends that clinicians take a careful medication history before interpreting results. This guidance applies more to daily aspirin users than to someone taking ibuprofen occasionally for a headache.
Preparing for a PSA Test
If you have a PSA screening coming up, you may have seen advice to stop taking ibuprofen beforehand. This guidance typically comes from preparation instructions for prostate biopsies, not for the PSA blood draw itself. Patients are often told to stop ibuprofen, aspirin, and naproxen a week before a biopsy because these drugs thin the blood and increase bleeding risk during the procedure.
For a routine PSA blood test, there’s no established guideline requiring you to stop ibuprofen. That said, telling your doctor about any medications you take regularly, including over-the-counter pain relievers, helps them interpret your results in context. If you’re a daily aspirin user, that’s especially worth mentioning, since aspirin has the strongest evidence for lowering PSA readings.
The Bigger Picture on Inflammation and PSA
PSA isn’t a cancer-specific marker. Prostate infections, benign prostate enlargement, recent ejaculation, vigorous cycling, and general inflammation can all push PSA higher. Anti-inflammatory drugs work by reducing inflammation throughout the body, including potentially in the prostate. In theory, this could bring an inflammation-driven PSA elevation back toward a truer baseline rather than artificially suppressing it.
A meta-analysis estimated that regular NSAID use was associated with a 10% to 30% reduction in prostate cancer risk overall. Whether that reflects a genuine protective effect or simply the type of men who take NSAIDs regularly is still debated. But it reinforces the point that these drugs don’t push PSA upward. If you’re taking ibuprofen and your PSA comes back elevated, the ibuprofen isn’t the explanation.